Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors

NCT05255159

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Active, Not Recruiting

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

NCT02293954

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

NCT05045027

Conditions: Glioma, Malignant Glioma, Neoplasms, +8 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

NCT01878617

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations: Lucille Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States

Rady Children's Hospital San Diego, California, United States

Yale University New Haven, Connecticut, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 23 locations

View Trial Details

Active, Not Recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions: Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Iowa City, Iowa, United States

GSK Investigational Site Hackensack, New Jersey, United States

GSK Investigational Site Cincinnati, Ohio, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

NCT04013854

Conditions: Melanoma, Melanoma Stage III, Neoplasms, +10 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

Lancaster General Hospital Lancaster, Pennsylvania, United States

Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

NCT04074967

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Genomic Structural Variation in Cancer Susceptibility

NCT00996710

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

NCT06148636

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +21 more
Locations: Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

NCT01223248

Conditions: Adnexal Diseases, Bone, CNS-Spinal CD/MEMBR, NOS, +35 more
Locations: University of California San Francisco San Francisco, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

University of Pisa Pisa, Italy

The Champalimaud Centre Lisbon, Portugal

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions